-
Je něco špatně v tomto záznamu ?
Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis
D. Spieler, A. Velayos-Baeza, A. Mühlbäck, F. Castrop, C. Maegerlein, J. Slotta-Huspenina, B. Bader, B. Haslinger, A. Danek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
Grantová podpora
Wellcome Trust - United Kingdom
090532/Z/09/Z
Wellcome Trust - United Kingdom
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-05-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Wiley-Blackwell Open Access Titles
od 2013
PubMed
32056394
DOI
10.1002/mgg3.1179
Knihovny.cz E-zdroje
- MeSH
- choreoakantocytóza diagnóza genetika MeSH
- delece genu * MeSH
- dospělí MeSH
- genetické testování metody MeSH
- heterozygot MeSH
- kvantitativní polymerázová řetězová reakce metody MeSH
- lidé MeSH
- vezikulární transportní proteiny genetika metabolismus MeSH
- western blotting metody MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
BACKGROUND: Chorea-acanthocytosis (ChAc; OMIM #200150) is a rare autosomal recessive condition with onset in early adulthood that is caused by mutations in the vacuolar protein sorting 13A (VPS13A) gene encoding chorein. Several diagnostic genomic DNA (gDNA) sequencing approaches are widely used. However, their limitations appear not to be acknowledged thoroughly enough. METHODS: Clinically, we deployed magnetic resonance imaging, blood smear analysis, and clinical chemistry for the index patient's characterization. The molecular analysis of the index patient next to his parents covered genomic DNA (gDNA) sequencing approaches, RNA/cDNA sequencing, and chorein specific Western blot. RESULTS: We report a 33-year-old male patient without functional protein due to compound heterozygosity for two VPS13A large deletions of 1168 and 1823 base pairs (bp) affecting, respectively, exons 8 and 9, and exon 13. To our knowledge, this represents the first ChAc case with two compound heterozygous large deletions identified so far. Of note, standard genomic DNA (gDNA) Sanger sequencing approaches alone yielded false negative findings. CONCLUSION: Our case demonstrates the need to carry out detection of chorein in patients suspected of having ChAc as a helpful and potentially decisive tool to establish diagnosis. Furthermore, the course of the molecular analysis in this case discloses diagnostic pitfalls in detecting some variations, such as deletions, using only standard genomic DNA (gDNA) Sanger sequencing approaches and exemplifies alternative methods, such as RNA/cDNA sequencing or qRT-PCR analysis, necessary to avoid false negative results.
Department of Neurology Klinikum rechts der Isar Technische Universität München Munich Germany
Department of Neuroradiology Klinikum rechts der Isar Technische Universität München Munich Germany
kbo Isar Amper Klinikum Taufkirchen Germany
Neurologische Klinik und Poliklinik Ludwigs Maximilians Universität München Munich Germany
Wellcome Centre for Human Genetics University of Oxford Oxford United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020211
- 003
- CZ-PrNML
- 005
- 20210830101835.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mgg3.1179 $2 doi
- 035 __
- $a (PubMed)32056394
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Spieler, Derek $u Department of Psychosomatic Medicine and Psychotherapy, Center for Mental Health, Faculty of Medicine, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany $u Institute of Epidemiology, Mental Health Research Unit, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 245 10
- $a Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis / $c D. Spieler, A. Velayos-Baeza, A. Mühlbäck, F. Castrop, C. Maegerlein, J. Slotta-Huspenina, B. Bader, B. Haslinger, A. Danek
- 520 9_
- $a BACKGROUND: Chorea-acanthocytosis (ChAc; OMIM #200150) is a rare autosomal recessive condition with onset in early adulthood that is caused by mutations in the vacuolar protein sorting 13A (VPS13A) gene encoding chorein. Several diagnostic genomic DNA (gDNA) sequencing approaches are widely used. However, their limitations appear not to be acknowledged thoroughly enough. METHODS: Clinically, we deployed magnetic resonance imaging, blood smear analysis, and clinical chemistry for the index patient's characterization. The molecular analysis of the index patient next to his parents covered genomic DNA (gDNA) sequencing approaches, RNA/cDNA sequencing, and chorein specific Western blot. RESULTS: We report a 33-year-old male patient without functional protein due to compound heterozygosity for two VPS13A large deletions of 1168 and 1823 base pairs (bp) affecting, respectively, exons 8 and 9, and exon 13. To our knowledge, this represents the first ChAc case with two compound heterozygous large deletions identified so far. Of note, standard genomic DNA (gDNA) Sanger sequencing approaches alone yielded false negative findings. CONCLUSION: Our case demonstrates the need to carry out detection of chorein in patients suspected of having ChAc as a helpful and potentially decisive tool to establish diagnosis. Furthermore, the course of the molecular analysis in this case discloses diagnostic pitfalls in detecting some variations, such as deletions, using only standard genomic DNA (gDNA) Sanger sequencing approaches and exemplifies alternative methods, such as RNA/cDNA sequencing or qRT-PCR analysis, necessary to avoid false negative results.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a western blotting $x metody $7 D015153
- 650 12
- $a delece genu $7 D017353
- 650 _2
- $a genetické testování $x metody $7 D005820
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a choreoakantocytóza $x diagnóza $x genetika $7 D054546
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $x metody $7 D060888
- 650 _2
- $a vezikulární transportní proteiny $x genetika $x metabolismus $7 D033921
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Velayos-Baeza, Antonio $u Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
- 700 1_
- $a Mühlbäck, Alžbeta $u kbo-Isar-Amper-Klinikum Taufkirchen (Vils), Taufkirchen (Vils), Germany $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital Prague, Prague, Czech Republic
- 700 1_
- $a Castrop, Florian $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 700 1_
- $a Maegerlein, Christian $u Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 700 1_
- $a Slotta-Huspenina, Julia $u Institut für Allgemeine Pathologie und Pathologische Anatomie der Technischen Universität München, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 700 1_
- $a Bader, Benedikt $u Neurologische Klinik und Poliklinik, Ludwigs-Maximilians Universität München, Munich, Germany
- 700 1_
- $a Haslinger, Bernhard $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 700 1_
- $a Danek, Adrian $u Neurologische Klinik und Poliklinik, Ludwigs-Maximilians Universität München, Munich, Germany
- 773 0_
- $w MED00205675 $t Molecular genetics & genomic medicine $x 2324-9269 $g Roč. 8, č. 9 (2020), s. e1179
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32056394 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101835 $b ABA008
- 999 __
- $a ok $b bmc $g 1690912 $s 1140657
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c 9 $d e1179 $e 20200214 $i 2324-9269 $m Molecular genetics & genomic medicine $n Mol Genet Genomic Med $x MED00205675
- GRA __
- $p Wellcome Trust $2 United Kingdom
- GRA __
- $a 090532/Z/09/Z $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20210728